AndrewEPlaceMDPhD

PubMed

• 3 citations
  Treatment completion, asparaginase completion, and oncologic outcomes among children, adolescents and young adults with acute lymphoblastic leukemia treated with DFCI ...
  Valtis, Y., Flamand, Y., Shimony, S., Place, A., Silverman, L., Vrooman, L., Brunner, A., Sallan, S., Wadleigh, M., Stone, R., DeAngelo, D., Luskin, M.> ;Leukemia. 2024 Mar 1
• 1 citations
  Integration of Genomic Sequencing Drives Therapeutic Targeting of PDGFRA in T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma.
  Paolino, J., Dimitrov, B., Apsel Winger, B., Sandoval-Perez, A., Rangarajan, A., Ocasio-Martinez, N., Tsai, H., Li, Y., Robichaud, A., Khalid, D., Hatton, C., Gillani,...> ;Clinical Cancer Research. 2023 Nov 14
• Treatment of recurrent pediatric myelodysplastic syndrome post hematopoietic stem cell transplantation.
  Franziska Wachter, Yana Pikman, Jacob Bledsoe, Malika Kapadia, Susanne Baumeister, Jared Rowe, Akiko Shimamura, Andrew E Place, Susan Prockop, Jennifer Whangbo, Leslie...> ;Clinical Case Reports. 2023 Nov 1
• Impairment of health-related quality of life for children with acute lymphoblastic leukemia over the first year of therapy: A report from the DFCI ALL Consortium.
  Jennifer J G Welch, Yael Flamand, Kristen E Stevenson, Donna S Neuberg, Uma H Athale, Kara M Kelly, Caroline Laverdiere, Bruno Michon, Andrew E Place, Stephen E Sallan...> ;Pediatric Blood & Cancer. 2023 Nov 1
• 2 citations
  Effect of BMI on toxicities and survival among adolescents and young adults treated on DFCI Consortium ALL trials.
  Shai Shimony, Yael Flamand, Yannis K Valtis, Andrew E Place, Lewis B Silverman, Lynda M Vrooman, Andrew M Brunner, Stephen E Sallan, Richard M Stone, Martha Wadleigh, ...> ;Blood Advances. 2023 Sep 26
• 7 citations
  Nelarabine combination therapy for relapsed or refractory T-cell acute lymphoblastic lymphoma/leukemia.
  Shai Shimony, Yiwen Liu, Yannis K Valtis, Jonathan D Paolino, Andrew E Place, Andrew M Brunner, Lachelle D Weeks, Lewis B Silverman, Lynda M Vrooman, Donna S Neuberg, ...> ;Blood Advances. 2023 Apr 11
• Orthopaedic adverse events among adolescents and adults treated with asparaginase for acute lymphoblastic leukaemia.
  Yannis K Valtis, Andrew E Place, Lewis B Silverman, Lynda M Vrooman, Daniel J DeAngelo, Marlise R Luskin> ;British Journal of Haematology. 2022 Aug 1
• Reply to: Comment on: Ocular abnormalities at diagnosis and after the completion of treatment in children and adolescents with newly diagnosed acute lymphoblastic leuk...
  Giacomo Gotti, Traci M Blonquist, Jason S Mantagos, Lewis B Silverman, Andrew E Place, Stevenson, K., Kay-Green, S.> ;Pediatric Blood & Cancer. 2023 Jan 1
• 19 citations
  Decitabine and vorinostat with FLAG chemotherapy in pediatric relapsed/refractory AML: Report from the therapeutic advances in childhood leukemia and lymphoma (TACL) c...
  Pommert, L., Schafer, E., Malvar, J., Gossai, N., Florendo, E., Pulakanti, K., Heimbruch, K., Stelloh, C., Chi, Y., Sposto, R., Rao, S., Huynh, V., Brown, P., Chang, B...> ;American Journal of Hematology. 2022 May 1
• 2 citations
  Ocular abnormalities at diagnosis and after the completion of treatment in children and adolescents with newly diagnosed acute lymphoblastic leukemia.
  Giacomo Gotti, Traci M Blonquist, Jason S Mantagos, Lewis B Silverman, Andrew E Place, Stevenson, K., Kay-Green, S.> ;Pediatric Blood & Cancer. 2022 Apr 1
• 9 citations
  B-cell acute lymphoblastic leukemia in patients with germline RUNX1 mutations.
  Kathryn A. Six, Ulrike Gerdemann, Anna L. Brown, Andrew E. Place, Alan B. Cantor, Matthew A. Kutny, Serine Avagyan> ;Blood Advances. 2021 Aug 24
• 5 citations
  Matched Targeted Therapy for Pediatric Patients with Relapsed, Refractory or High-risk Leukemias: A Report from the LEAP Consortium
  , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , > ;Cancer Discovery. 2021 Jun 1
• 6 citations
  Retrospective evaluation of single patient investigational new drug (IND) requests in pediatric oncology
  David S. Shulman, Lulla V Kiwinda, Stacey Edwards, Catherine Clinton, Sarah K. Hunt, Lianne Greenspan, Kristen Lawler, Gregory H. Reaman, Hasan Al-Sayegh, Kira Bona, A...> ;Cancer Medicine. 2021 Mar 9
• Corrigendum to: Identification of prognostic factors in childhood T-cell acute lymphoblastic leukemia: Results from DFCI ALL Consortium Protocols 05-001 and 11-001 (Pe...
  Melissa A. Burns, Andrew E. Place, Kristen E. Stevenson, Alejandro Gutierrez, Suzanne J. Forrest, Yana Pikman, Lynda M. Vrooman, Marian H. Harris, Olga K. Weinberg, Sa...> ;Pediatric Blood & Cancer. 2021 Mar 1
• 23 citations
  Identification of prognostic factors in childhood T-cell acute lymphoblastic leukemia: Results from DFCI ALL Consortium Protocols 05-001 and 11-001.
  Melissa A. Burns, Andrew E. Place, Kristen E. Stevenson, Alejandro Gutierrez, Suzanne J. Forrest, Yana Pikman, Lynda M. Vrooman, Marian H. Harris, Sarah K. Hunt, Jane ...> ;Pediatric Blood & Cancer. 2021 Jan 1
• 28 citations
  Single-cell RNA-seq reveals developmental plasticity with coexisting oncogenic states and immune evasion programs in ETP-ALL
  Praveen Anand, Amy Guillaumet-Adkins, Valeriya Dimitrova, Huiyoung Yun, Yotam Drier, Noori Sotudeh, Anna Jollyette Rogers, Madhu M. Ouseph, Monica S. Nair, Sayalee Pot...> ;Blood. 2021 May 6
• 6 citations
  Orthopedic Toxicity Among Adolescents and Young Adults Treated on DFCI ALL Consortium Trials
  Yannis K. Valtis, Kristen E. Stevenson, Andrew E. Place, Lewis B. Silverman, Lynda M. Vrooman, Giacomo Gotti, Andrew M. Brunner, Mary Nauffal, Daniel J. DeAngelo, Marl...> ;Blood Advances. 2020 Nov 5
• 14 citations
  Limiting Vancomycin Exposure in Pediatric Oncology Patients With Febrile Neutropenia May Be Associated With Decreased Vancomycin-Resistant Enterococcus Incidence.
  Manjiree V. Karandikar, Carly E. Milliren, Robin Zaboulian, Poornima Peiris, Tanvi Sharma, Andrew E. Place, Thomas J. Sandora> ;Journal of the Pediatric Infectious Diseases Society. 2019 Oct 11
• 29 citations
  Efficacy and Toxicity of Pegaspargase and Calaspargase Pegol in Childhood Acute Lymphoblastic Leukemia: Results of DFCI 11-001
  , , , , , , , , , , , , , , , , , , , , > ;Journal of Clinical Oncology. 2019 May 26
• A single institutional review of pediatric Bacillus spp. bloodstream infections demonstrates increased incidence among children with cancer.
  David S. Shulman, Preeti Mehrotra, Traci M. Blonquist, Andrew Capraro, Leslie Lehmann, Lewis B. Silverman, Neeraj K. Surana, Andrew E. Place> ;Pediatric Blood & Cancer. 2018 Dec 11
• 65 citations
  Refining risk classification in childhood B acute lymphoblastic leukemia: results of DFCI ALL Consortium Protocol 05-001.
  Lynda M. Vrooman, Traci M. Blonquist, Marian H. Harris, Kristen E. Stevenson, Andrew E. Place, Sarah K. Hunt, Jane E. O'Brien, Barbara L. Asselin, Uma H. Athale, Luis ...> ;Blood Advances. 2018 Jun 26
• 43 citations
  Phase I trial of the mTOR inhibitor everolimus in combination with multi-agent chemotherapy in relapsed childhood acute lymphoblastic leukemia.
  Andrew E. Place, Yana Pikman, Kristen E. Stevenson, Marian H. Harris, Melinda Pauly, Maria Luisa Sulis, Nobuko Hijiya, Lia Gore, Todd M. Cooper, Mignon L. Loh, Giovann...> ;Pediatric Blood & Cancer. 2018 Jul 1
• 43 citations
  Accelerating drug development in pediatric cancer: a novel Phase I study design of venetoclax in relapsed/refractory malignancies.
  Andrew E. Place, Kelly C. Goldsmith, Jean-Pierre Bourquin, Mignon L. Loh, Lia Gore, Daniel A. Morgenstern, Yeshwant D. Sanzgiri, David Hoffman, Ying Zhou, Jeremy A. Ro...> ;Future Oncology. 2018 Mar 29
• 80 citations
  Outcome of children with multiply relapsed B-cell acute lymphoblastic leukemia: a therapeutic advances in childhood leukemia & lymphoma study.
  Weili Sun, Jemily Malvar, Richard Sposto, Anupam Verma, Jennifer J. Wilkes, Robyn M. Dennis, Kenneth Heym, Theodore W. Laetsch, Melissa Widener, Susan R. Rheingold, Ja...> ;Leukemia. 2018 Mar 15
• 58 citations
  Dasatinib in Pediatric Patients With Chronic Myeloid Leukemia in Chronic Phase: Results From a Phase II Trial.
  Lia Gore, Pamela Kearns, Maria Lucia de Martino Lee, Carmino Antonio De Souza, Yves Bertrand, Nobuko Hijiya, Linda C. Stork, Nack Gyun Chung, Rocio Cardenas Cardos, Ta...> ;Journal of Clinical Oncology. 2018 Mar 2
• Join now to see all

Abstracts/Posters

• Safety, Efficacy, and PK of the BCL2 Inhibitor Venetoclax in Combination with Chemotherapy in Pediatric and Young Adult Patients with Relapsed/Refractory Acute Myeloid...
  Andrew E. Place, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

• Pediatric Clinical Malignant Hematology 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Matched Targeted Therapy for Pediatric Patients with Relapsed, Refractory or High-Risk Leukemias: A Report from the LEAP ConsortiumClinically Relevant Abstract 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Phase I Study of the Selinexor in Relapsed/Refractory Childhood Acute Leukemia 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018